Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PDUFA public meeting

This article was originally published in The Tan Sheet

Executive Summary

FDA will host a public meeting to gather stakeholder feedback on the Prescription Drug User Fee Act (PDUFA) Nov. 14 from 9 a.m. to 5 p.m. The agency requests that the public consider two questions in preparation for the meeting or submitted comments: "What is your assessment of the overall performance of the PDUFA programs thus far?" and "What aspects of PDUFA should be retained, or what should be changed to further strengthen and improve the program?" Current PDUFA legislation will expire in September 2007. Those planning to attend the meeting must be registered by Oct. 31 and written comments must be submitted by Dec. 14, FDA states...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS098761

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel